Recent neuroscience research evaluated multiple levels of cognitive and emotional complexity in Parkinson’s Disease patients with Pathological Gambling by combining distinct measurement tools with a multi-method approach. However, no previous studies specifically targeted metacognition in this population. Instead, to differentiate between patients that not only show vulnerable individual differences but might also have a reduced self-awareness could help in developing tailored clinical interventions that give the right space to metacognition.
- Parkinson's Disease
- Pathological Gambling